ENDP

Endo (ENDP)

Endo International PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ENDP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/09/21	20:45	PR Newswire (Canada)	Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting	NASDAQ:ENDP	Endo International PLC
2023/09/21	20:45	PR Newswire (US)	Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting	NASDAQ:ENDP	Endo International PLC
2023/08/08	20:45	PR Newswire (US)	ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
2023/08/08	20:45	PR Newswire (Canada)	ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
2023/07/19	05:30	PR Newswire (US)	Endo Launches Bivalirudin Injection in Ready-to-Use Vials	NASDAQ:ENDP	Endo International PLC
2023/07/14	05:30	PR Newswire (US)	Endo Presents New Data at the American Podiatric Medical Association Annual Meeting	NASDAQ:ENDP	Endo International PLC
2023/06/30	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2023/06/12	20:30	PR Newswire (US)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
2023/06/12	20:30	PR Newswire (US)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
2023/06/12	20:30	PR Newswire (Canada)	Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe	NASDAQ:ENDP	Endo International PLC
2023/05/08	20:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2023/05/08	20:30	PR Newswire (US)	ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS	NASDAQ:ENDP	Endo International PLC
2023/04/17	20:45	PR Newswire (US)	Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program	NASDAQ:ENDP	Endo International PLC
2023/04/04	05:30	PR Newswire (Canada)	Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension	NASDAQ:ENDP	Endo International PLC
2023/04/04	05:30	PR Newswire (US)	Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension	NASDAQ:ENDP	Endo International PLC
2023/03/14	05:17	PR Newswire (US)	Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis	NASDAQ:ENDP	Endo International PLC
2023/03/10	21:30	PR Newswire (US)	Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules	NASDAQ:ENDP	Endo International PLC
2023/03/07	06:14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ENDP	Endo International PLC
2023/03/06	23:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2023/03/06	23:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2023/02/28	07:15	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
2023/02/28	07:10	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
2023/02/28	07:05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENDP	Endo International PLC
2023/02/28	07:00	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:ENDP	Endo International PLC
2023/02/14	23:00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2023/02/14	02:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENDP	Endo International PLC
2023/02/06	21:30	PR Newswire (US)	Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease	NASDAQ:ENDP	Endo International PLC
2023/02/01	07:06	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ENDP	Endo International PLC
2022/12/23	06:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENDP	Endo International PLC
2022/12/07	06:45	PR Newswire (US)	Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)	NASDAQ:ENDP	Endo International PLC